BR0306976A - Composto, formulação de aerossol farmacêutica, inalador de dose medida, uso de uma formulação, uso de um composto, e, processo para a preparação dos compostos - Google Patents
Composto, formulação de aerossol farmacêutica, inalador de dose medida, uso de uma formulação, uso de um composto, e, processo para a preparação dos compostosInfo
- Publication number
- BR0306976A BR0306976A BR0306976-1A BR0306976A BR0306976A BR 0306976 A BR0306976 A BR 0306976A BR 0306976 A BR0306976 A BR 0306976A BR 0306976 A BR0306976 A BR 0306976A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- formulation
- compounds
- pharmaceutical aerosol
- dose inhaler
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 8
- 238000009472 formulation Methods 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 6
- 239000008249 pharmaceutical aerosol Substances 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940071648 metered dose inhaler Drugs 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000003709 fluoroalkyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical group FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q9/00—Preparations for removing hair or for aiding hair removal
- A61Q9/04—Depilatories
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/62—Halogen-containing esters
- C07C69/63—Halogen-containing esters of saturated acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0203363A GB0203363D0 (en) | 2002-02-13 | 2002-02-13 | Novel compounds |
| GB0203369A GB0203369D0 (en) | 2002-02-13 | 2002-02-13 | Novel compounds |
| PCT/GB2003/000547 WO2003068722A1 (en) | 2002-02-13 | 2003-02-12 | Carboxylic acid compounds for use as surfactants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0306976A true BR0306976A (pt) | 2004-12-14 |
Family
ID=27736206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0306976-1A BR0306976A (pt) | 2002-02-13 | 2003-02-12 | Composto, formulação de aerossol farmacêutica, inalador de dose medida, uso de uma formulação, uso de um composto, e, processo para a preparação dos compostos |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7217833B2 (https=) |
| EP (1) | EP1474376A1 (https=) |
| JP (1) | JP2005517701A (https=) |
| KR (1) | KR20040086370A (https=) |
| CN (1) | CN1633407A (https=) |
| AU (1) | AU2003205860A1 (https=) |
| BR (1) | BR0306976A (https=) |
| CA (1) | CA2474626A1 (https=) |
| CO (1) | CO5611094A2 (https=) |
| IL (1) | IL162752A0 (https=) |
| IS (1) | IS7336A (https=) |
| MX (1) | MXPA04007899A (https=) |
| NO (1) | NO20043743L (https=) |
| NZ (1) | NZ533831A (https=) |
| PL (1) | PL372106A1 (https=) |
| RU (1) | RU2004120550A (https=) |
| WO (1) | WO2003068722A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5172188B2 (ja) * | 2007-03-28 | 2013-03-27 | 富士フイルム株式会社 | フッ素置換アルキル基を有するグリセリド化合物 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4352789A (en) | 1980-03-17 | 1982-10-05 | Minnesota Mining And Manufacturing Company | Aerosol compositions containing finely divided solid materials |
| US4535177A (en) * | 1983-11-14 | 1985-08-13 | Usv Pharmaceutical Corp. | N-substituted amino acid derivatives |
| GB8828477D0 (en) | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
| GB8921222D0 (en) | 1989-09-20 | 1989-11-08 | Riker Laboratories Inc | Medicinal aerosol formulations |
| IL97065A (en) | 1990-02-02 | 1994-01-25 | Fisons Plc | Repellent preparations for aerosol |
| DE4003272A1 (de) | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen |
| AU654813B2 (en) | 1990-03-23 | 1994-11-24 | Minnesota Mining And Manufacturing Company | The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
| DE69101639T2 (de) | 1990-06-27 | 1994-10-06 | Minnesota Mining & Mfg | Anwendung von löslichen fluorhaltigen tensiden zur herstellung von aerosol-präparaten mit dosierter abgabe. |
| US5126123A (en) | 1990-06-28 | 1992-06-30 | Glaxo, Inc. | Aerosol drug formulations |
| CA2085884C (en) | 1990-06-29 | 2001-12-04 | Asit Somani | Pressurized hydrofluorocarbon aerosol compositions |
| US5376359A (en) * | 1992-07-07 | 1994-12-27 | Glaxo, Inc. | Method of stabilizing aerosol formulations |
| GB9419536D0 (en) * | 1994-09-28 | 1994-11-16 | Glaxo Inc | Medicaments |
| AP791A (en) | 1995-04-14 | 1999-12-17 | Glaxo Wellcome Inc | Metered dose inhaler for albuterol. |
| US6376359B1 (en) | 1998-03-18 | 2002-04-23 | United Microelectronics Corp. | Method of manufacturing metallic interconnect |
| US6451287B1 (en) | 2000-05-26 | 2002-09-17 | Smithkline Beecham Corporation | Fluorinated copolymer surfactants and use thereof in aerosol compositions |
| US7217409B2 (en) | 2000-09-22 | 2007-05-15 | Smithkline Beecham Corporation | Alkanoic acid derivatives |
| WO2003013610A2 (en) | 2001-08-03 | 2003-02-20 | Glaxo Group Limited | Surfactant compounds and uses thereof |
| GB0125127D0 (en) | 2001-10-19 | 2001-12-12 | Glaxo Group Ltd | Compounds |
-
2003
- 2003-02-12 KR KR10-2004-7012501A patent/KR20040086370A/ko not_active Withdrawn
- 2003-02-12 PL PL03372106A patent/PL372106A1/xx not_active Application Discontinuation
- 2003-02-12 WO PCT/GB2003/000547 patent/WO2003068722A1/en not_active Ceased
- 2003-02-12 NZ NZ533831A patent/NZ533831A/en unknown
- 2003-02-12 CA CA002474626A patent/CA2474626A1/en not_active Abandoned
- 2003-02-12 BR BR0306976-1A patent/BR0306976A/pt not_active IP Right Cessation
- 2003-02-12 EP EP03702738A patent/EP1474376A1/en not_active Withdrawn
- 2003-02-12 MX MXPA04007899A patent/MXPA04007899A/es unknown
- 2003-02-12 CN CNA038038633A patent/CN1633407A/zh active Pending
- 2003-02-12 AU AU2003205860A patent/AU2003205860A1/en not_active Abandoned
- 2003-02-12 JP JP2003567857A patent/JP2005517701A/ja active Pending
- 2003-02-12 IL IL16275203A patent/IL162752A0/xx unknown
- 2003-02-12 US US10/504,252 patent/US7217833B2/en not_active Expired - Fee Related
- 2003-02-12 RU RU2004120550/04A patent/RU2004120550A/ru not_active Application Discontinuation
-
2004
- 2004-06-28 IS IS7336A patent/IS7336A/is unknown
- 2004-08-10 CO CO04077756A patent/CO5611094A2/es not_active Application Discontinuation
- 2004-09-07 NO NO20043743A patent/NO20043743L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2474626A1 (en) | 2003-08-21 |
| MXPA04007899A (es) | 2004-10-15 |
| WO2003068722A1 (en) | 2003-08-21 |
| US20050163720A1 (en) | 2005-07-28 |
| IL162752A0 (en) | 2005-11-20 |
| PL372106A1 (en) | 2005-07-11 |
| IS7336A (is) | 2004-06-28 |
| US7217833B2 (en) | 2007-05-15 |
| NZ533831A (en) | 2006-04-28 |
| NO20043743L (no) | 2004-09-07 |
| EP1474376A1 (en) | 2004-11-10 |
| AU2003205860A1 (en) | 2003-09-04 |
| CN1633407A (zh) | 2005-06-29 |
| KR20040086370A (ko) | 2004-10-08 |
| RU2004120550A (ru) | 2005-05-27 |
| CO5611094A2 (es) | 2006-02-28 |
| JP2005517701A (ja) | 2005-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9911488A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto | |
| BR0214142A (pt) | Derivados e intermediários de n-adamantilmetila como composições farmacêuticas e processos para sua preparação | |
| MEP24508A (en) | Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | |
| BR0112224A (pt) | Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto | |
| BRPI0316532B8 (pt) | composições farmacêuticas compreendendo uma droga básica ou ácida, um tensoativo, e um ácido ou base solúvel em água fisiologicamente tolerável | |
| BRPI0215312B8 (pt) | composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto | |
| BRPI0212455B8 (pt) | composto derivado de fenetanolamina para o tratamento de doenças respiratórias, formulação farmacêutica, combinação, e, uso do mesmo | |
| BR0111667A (pt) | Novos compostos | |
| BR9907270A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto | |
| BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
| BR0212185A (pt) | Compostos e métodos para a preparação de compostos | |
| PA8582801A1 (es) | Nuevos derivados espirotricíclicos y su uso como inhibidores de la fosfodiesterasa | |
| BR0010520A (pt) | Novos compostos farmaceuticamente ativos | |
| BR0214243A (pt) | Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida | |
| BRPI0407734A (pt) | derivados de adamantano, processo para sua preparação e composições farmacêuticas os contendo | |
| BRPI0113162B8 (pt) | compostos ariloxialquilaminas nao-imidazólicos e composição farmacêutica compreendendo os referidos compostos | |
| NO20000466D0 (no) | Farmasoeytisk preparat for sure, lipofile forbindelser i form av en selvemulgerende formulering | |
| BR0212069A (pt) | Agentes antidiabéticos orais | |
| SE9904413D0 (sv) | Comminuted form | |
| BR0012478A (pt) | Derivados de aminotiazóis, sua preparação e composição farmacêuticas contendo os mesmos | |
| BR0210207A (pt) | Derivados de pirrolidina como inibidores do fator xa | |
| BR0309896A (pt) | Compostos, uso em um composto, composição farmacêutica, composição cosmética, uso cosmético de uma composição | |
| BR0111669A (pt) | Novos compostos | |
| BR0104471A (pt) | Compostos de ciclobutenodiona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos | |
| BRPI0414644A (pt) | composto, composições farmacêuticas, e, uso de um composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5O, 6O E 7O ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2047 DE 30/03/2010. |